Approved for marketing trials in Turkey (Türkiye)

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

• Influence of Preoperative Enema Application on Return of Gastrointestinal Function After Elective Cesarean Section: A Randomized Controlled Study NCT01917396·Expanded access·Approved for marketing·Istanbul Bakirkoy Maternity and Children Diseases Hospital·Started 2013
• Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma NCT00130897·Expanded access·Approved for marketing·Pfizer·Started 2005
• A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor (GIST) Who May Derive Benefit From Treatment With SU011248 NCT00094029·Expanded access·Approved for marketing·Pfizer·Started 2004
• TMC114-C226: An Early Access Program to Evaluate the Long-term Safety and Tolerability of TMC114 Combined With a Low Dose of Ritonavir (TMC114/r) With Other Antiretrovirals, for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens. NCT00245739·Expanded access·Approved for marketing·Tibotec Pharmaceuticals, Ireland
• The TMC125-C214 Study Provides Early Access to TMC125 for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens and Will Also Gather Information on the Long-term Safety and Tolerability of TMC125 Combined With Other Antiretroviral Drugs NCT00354627·Expanded access·Approved for marketing·Tibotec Pharmaceuticals, Ireland
• Open Label Extension Study With Gefitinib (IRESSA™) for Completing Trial Patients Who May Benefit From Further Treatment NCT00683306·Expanded access·Approved for marketing·AstraZeneca